Glenmark Pharmaceuticals informs about press release

01 Dec 2025 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Glenmark Pharmaceuticals has informed that the U.S. Food and Drug Administration (U.S. FDA) completed Pre-Approval Inspection at the Company’s formulations manufacturing facility in Chhatrapati Sambhajinagar (Aurangabad). The inspection was carried out from November 24 to November 28, 2025, and concluded with zero 483 observations.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1977.50 3.35 (0.17%)
05-Dec-2025 14:20 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1807.80
Dr. Reddys Lab 1275.00
Cipla 1524.60
Zydus Lifesciences 933.35
Lupin 2101.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×